Franklin Genomic Advancements Etf (HELX) Technical Analysis
$34.53▲0.44%
Insights
- Franklin Genomic Advancements Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Franklin Genomic Advancements Etf stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 67.12 | Sell |
Stochastic | 100.0, 81.02 | Neutral |
Ultimate Oscillator | 70.18 | Sell |
Stochastic Relative Strength Index | 31.01, 22.18 | Neutral |
Moving Average Convergence Divergence | 0.78, 0.83 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.86 | Buy |
20 | 34.32 | Buy |
50 | 32.42 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.76 | Buy |
20 | 34.23 | Buy |
50 | 32.71 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.85 | Neutral |
20 | 33.75 | Neutral |
50 | 31.84 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 35.18 | Sell |
20 | 35.31 | Buy |
50 | 34.78 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 35.08 | Sell |
20 | 35.3 | Sell |
50 | 35.45 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 35.41 |
Resistance L2 | 35.16 |
Resistance L1 | 35.03 |
Pivot Point | 34.78 |
Support L1 | 34.66 |
Support L2 | 34.41 |
Support L3 | 34.28 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.